Investor Overview

KindredBio is focused on bringing breakthrough human products and innovative new technologies to veterinary medicine to address unmet clinical needs and provide benefits to animal co... 

Stock Information

NASDAQ CM$9.65
Change (%) + 0.35 (3.76%)
Volume99,773
Data as of 04/20/18 4:00 p.m. ET
Refresh quote
Data provided by Nasdaq. Minimum 15 minutes delayed.

NEWS

Kindred Biosciences to Announce First Quarter 2018 Financial Results

April 18, 2018

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m... 

Kindred Biosciences to Present at the Oppenheimer 28th Annual Healthcare Conference

March 8, 2018

SAN FRANCISCO, March 8, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ... 

Kindred Biosciences Announces Fourth Quarter and Full Year 2017 Financial Results

March 1, 2018

SAN FRANCISCO, March 1, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ...